Target Price | $11.77 |
Price | $1.85 |
Potential |
536.14%
register free of charge
|
Number of Estimates | 7 |
7 Analysts have issued a price target Alto Neuroscience 2026 .
The average Alto Neuroscience target price is $11.77.
This is
536.14%
register free of charge
$18.00
872.97%
register free of charge
$4.00
116.22%
register free of charge
|
|
A rating was issued by 8 analysts: 6 Analysts recommend Alto Neuroscience to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Alto Neuroscience stock has an average upside potential 2026 of
536.14%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -2.50 | -2.92 |
85.19% | 16.80% | |
P/E | negative |
3 Analysts have issued a Alto Neuroscience forecast for earnings per share. The average Alto Neuroscience EPS is
This results in the following potential growth metrics and future valuations:
Alto Neuroscience...
Analyst | Rating | Action | Date |
---|---|---|---|
Jones Trading |
Locked
➜
Locked
|
Locked | Dec 16 2024 |
Stifel |
Locked
➜
Locked
|
Locked | Nov 13 2024 |
Baird |
Locked
➜
Locked
|
Locked | Oct 23 2024 |
Wedbush |
Locked
➜
Locked
|
Locked | Oct 23 2024 |
Wedbush |
Locked
➜
Locked
|
Locked | Sep 10 2024 |
Wedbush |
Locked
➜
Locked
|
Locked | Sep 03 2024 |
Analyst Rating | Date |
---|---|
Locked
Jones Trading:
Locked
➜
Locked
|
Dec 16 2024 |
Locked
Stifel:
Locked
➜
Locked
|
Nov 13 2024 |
Locked
Baird:
Locked
➜
Locked
|
Oct 23 2024 |
Locked
Wedbush:
Locked
➜
Locked
|
Oct 23 2024 |
Locked
Wedbush:
Locked
➜
Locked
|
Sep 10 2024 |
Locked
Wedbush:
Locked
➜
Locked
|
Sep 03 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.